---
title: "12 Health Care Stocks Moving In Thursday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293614996.md"
description: "In Thursday's pre-market session, several healthcare stocks saw significant movement. Gainers included Niki BioSolutions (+44.7%), Zhengye Biotechnology (+20.3%), First Tracks (+19.4%), Medpace Holdings (+18.5%), GMR Solutions (+15.6%), and NovoCure (+13.3%), with some moves linked to Q2 earnings reports. Conversely, losers comprised China SXT Pharmaceuticals (-25.7%), Nuwellis (-16.5%), SANUWAVE Health (-14.1%), Community Health System (-13.1%), MindWalk Holdings (-12.5%), and Autonomix Medical (-12.1%)."
datetime: "2026-07-23T12:06:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293614996.md)
  - [en](https://longbridge.com/en/news/293614996.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293614996.md)
---

# 12 Health Care Stocks Moving In Thursday's Pre-Market Session

### Gainers

-   **Niki BioSolutions** (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) shares increased by 20.28% to $1.66. The market value of their outstanding shares is at $65.4 million.
-   **First Tracks** (NASDAQ:TRAX) stock rose 19.43% to $45.59. The company's market cap stands at $1.3 billion.
-   **Medpace Holdings** (NASDAQ:MEDP) stock increased by 18.46% to $625.62. The company's market cap stands at $15.0 billion. As per the news, the Q2 earnings report came out yesterday.
-   **GMR Solutions** (NYSE:GMRS) stock moved upwards by 15.62% to $14.8. The market value of their outstanding shares is at $691.3 million.
-   **NovoCure** (NASDAQ:NVCR) shares increased by 13.3% to $17.64. The market value of their outstanding shares is at $1.8 billion. As per the news, the Q2 earnings report came out today.

### Losers

-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock declined by 25.7% to $1.5 during Thursday's pre-market session. The company's market cap stands at $77.2 million.
-   **Nuwellis** (NASDAQ:NUWE) stock fell 16.5% to $2.38.
-   **SANUWAVE Health** (NASDAQ:SNWV) shares decreased by 14.12% to $5.11. The market value of their outstanding shares is at $51.1 million.
-   **Community Health System** (NYSE:CYH) shares declined by 13.05% to $2.8. The market value of their outstanding shares is at $453.7 million. As per the press release, Q2 earnings came out yesterday.
-   **MindWalk Holdings** (NASDAQ:HYFT) stock decreased by 12.5% to $1.26. The company's market cap stands at $67.2 million. As per the press release, Q4 earnings came out yesterday.
-   **Autonomix Medical** (NASDAQ:AMIX) shares fell 12.07% to $3.5. The market value of their outstanding shares is at $2.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [HYFT.US](https://longbridge.com/en/quote/HYFT.US.md)
- [CYH.US](https://longbridge.com/en/quote/CYH.US.md)
- [NVCR.US](https://longbridge.com/en/quote/NVCR.US.md)
- [MEDP.US](https://longbridge.com/en/quote/MEDP.US.md)
- [TRAX.US](https://longbridge.com/en/quote/TRAX.US.md)
- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)
- [GMRS.US](https://longbridge.com/en/quote/GMRS.US.md)
- [NIKI.US](https://longbridge.com/en/quote/NIKI.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [SNWV.US](https://longbridge.com/en/quote/SNWV.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)

## Related News & Research

- [NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery](https://longbridge.com/en/news/293689613.md)
- [Community Health Q2 revenue falls more than expected, hurt by sale of hospitals](https://longbridge.com/en/news/293517458.md)
- [HealthTrust Performance Group Celebrates 2026 Member Excellence](https://longbridge.com/en/news/293498358.md)
- [Charles Rhyee Maintains Hold Rating, Raises Price Target to $492 Amid Near-Term Strength and 2027 Metabolic Concentration Risks](https://longbridge.com/en/news/293679554.md)
- [HC Wainwright Estimates MindWalk FY2031 Earnings](https://longbridge.com/en/news/293751126.md)